Delivery Order SPE2DB22D1202-SPE2DB23FHTM6
Award Date 6/26/23
Potential Completion Date 6/27/23
Potential Value $594
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $502,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy. The single order is for product delivery to a location in Conshohocken, Pennsylvania by July 19, 2023 to support the DLA's medical supply needs. Amerisourcebergen will perform as the prime contractor, drawing upon its extensive pharmaceutical distribution capabilities. The award is made...
- The Defense Logistics Agency awarded a $798 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility from July 7-10, 2023. The prime contractor, a pharmaceutical wholesaler and distributor, will fulfill this order under an existing DLA-managed contract vehicle to support the agency's medical supply needs. No...
- The Defense Logistics Agency awarded a $560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will take place in Conshohocken, Pennsylvania under the terms of the order placed from August 21-22, 2023. As a major provider of medical supplies and pharmaceuticals, Amerisourcebergen will fulfill this small quantity order of a specialty drug to support the DLA's procurement programs...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,727 to Amerisourcebergen Drug Corporation for the supply of 50 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone replacement drug. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in mid-July 2023. Amerisourcebergen Corporation is the identified parent company. No subcontractors or set aside designations were indicated. This order...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $940 to Amerisourcebergen Drug Corporation for 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on August 29, 2023. The delivery order was issued under Amerisourcebergen Corporation's corporate office division contract vehicle and...
- The Defense Logistics Agency awarded a $1,005.72 delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone replacement drug. As the prime contractor, Amerisourcebergen will deliver the doses from its Conshohocken, Pennsylvania facility under a firm fixed price contract ending August 10, 2023. No set-aside designation or subcontractors were identified. This order was placed under an existing DLA pharmaceuticals contract vehicle to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,116 to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late August 2023. The prime contractor, a pharmaceutical distribution division of Amerisourcebergen Corporation, will deliver the requested doses...
- The Defense Logistics Agency awarded a $502,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy. The single order is for product delivery to a facility in Conshohocken, Pennsylvania by August 15, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen will perform as the prime contractor, with product sourcing and delivery managed through its Corporate Office...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,006 to Amerisourcebergen Drug Corporation for the supply of 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone replacement drug. The single day order is to be fulfilled from Amerisourcebergen's distribution center in Conshohocken, Pennsylvania under the parent company Amerisourcebergen Corporation's federal supply schedule contract with the DLA. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $762 delivery order to Amerisourcebergen Drug Corporation for XYOSTED 50 MG/0.5 ML auto-injectors. The firm fixed-price order calls for delivery of the injectable testosterone replacement drug to a location in Conshohocken, Pennsylvania by July 3, 2023 in support of Department of Defense pharmacotherapy programs. Amerisourcebergen will serve as the prime contractor, drawing from its extensive inventory of pharmaceutical products to fulfill agency...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FHTM6Delivery Order
The Defense Logistics Agency awarded a $594.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone medication. The single order is for delivery to a location in Conshohocken, Pennsylvania by June 27, 2023 to support DLA programs. Amerisourcebergen will perform as the prime contractor, drawing upon its extensive pharmaceutical distribution capabilities to fulfill agency needs on schedule from its corporate headquarters. No major subcontractors or set aside designations were indicated.
Generated 12/23/23, 12:22 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $594 | 6/26/23 |